LFB’s 15 hospital-prescribed biopharmaceuticals are used for treating disorders that are always serious and often rare. LFB has acknowledged expertise in three major therapeutic fields: immunology, intensive care, and haemostasis.
More than two-thirds of LFB’s prescribed medicinal products are for patients with a rare disease
One product in pulmonology : LFB offers replacement therapy indicated in alpha-1 antitrypsin deficiency